awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q30444892-9B6B3D06-B40F-480B-92DF-FBC554F17C98
Q30444892-9B6B3D06-B40F-480B-92DF-FBC554F17C98
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30444892-9B6B3D06-B40F-480B-92DF-FBC554F17C98
Cost effectiveness of peginterferon alpha-2b plus ribavirin versus interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C.
P2860
Q30444892-9B6B3D06-B40F-480B-92DF-FBC554F17C98
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30444892-9B6B3D06-B40F-480B-92DF-FBC554F17C98
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
79c77b1d06848d813085ba7e3f6995ab0b454da1
P2860
Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group.